Home Cart Sign in  
Chemical Structure| 1449685-96-4 Chemical Structure| 1449685-96-4

Structure of DDR1-IN-1
CAS No.: 1449685-96-4

Chemical Structure| 1449685-96-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

DDR1-IN-1 is a potent and selective DDR1 receptor tyrosine kinase inhibitor with IC50/EC50 of 105 nM/87 nM and 4-fold less potent for DDR2 (IC50= 413 nM).

Synonyms: DDR1-IN-1

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of DDR1-IN-1

CAS No. :1449685-96-4
Formula : C30H31F3N4O3
M.W : 552.59
SMILES Code : O=C(NC1=CC=C(C)C(OC2=CC3=C(NC(C3)=O)C=C2)=C1)C4=CC=C(CN5CCN(CC)CC5)C(C(F)(F)F)=C4
Synonyms :
DDR1-IN-1
MDL No. :MFCD28144507

Safety of DDR1-IN-1

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H413
Precautionary Statements:P264-P270-P273-P301+P312-P330

Related Pathways of DDR1-IN-1

RTK

Isoform Comparison

Biological Activity

Description
DDR1-IN-1 exhibits potent and selective inhibition of the DDR1 receptor tyrosine kinase, with an IC50 of 105 nM. It is approximately four times less potent for DDR2, with an IC50 of 413 nM[1].

In Vitro:

Cell Line
Concentration Treated Time Description References
SkBr3 cells >10 μM Anti-proliferation effect ACS Chem Biol. 2013 Oct 18;8(10):2145-50.
SaoS2 cells 8.14 μM Anti-proliferation effect ACS Chem Biol. 2013 Oct 18;8(10):2145-50.
H1975 cells >10 μM Anti-proliferation effect ACS Chem Biol. 2013 Oct 18;8(10):2145-50.
A549 cells >10 μM Anti-proliferation effect ACS Chem Biol. 2013 Oct 18;8(10):2145-50.
T47D cells >10 μM Anti-proliferation effect ACS Chem Biol. 2013 Oct 18;8(10):2145-50.
HCT-116 cells 8.7 μM Anti-proliferation effect ACS Chem Biol. 2013 Oct 18;8(10):2145-50.
U2OS cells 86 nM Inhibition of DDR1 autophosphorylation ACS Chem Biol. 2013 Oct 18;8(10):2145-50.
MPNST cell line STS26T 1-10 µM 24 h Detect LC3B-II accumulation, DDR1-IN-1 dose-dependently induced autophagy Cell Death Discov. 2025 Mar 1;11(1):83.
MPNST cell line S462 12.4 µM (IC50) 48 h Assess cell viability, DDR1-IN-1 drastically reduced cell viability within a narrow concentration range Cell Death Discov. 2025 Mar 1;11(1):83.
SNU-449 cells >10 μM Anti-proliferation effect ACS Chem Biol. 2013 Oct 18;8(10):2145-50.
EJ cells >10 μM Anti-proliferation effect ACS Chem Biol. 2013 Oct 18;8(10):2145-50.
SNU-1040 cells >10 μM Anti-proliferation effect ACS Chem Biol. 2013 Oct 18;8(10):2145-50.
SW480 cells >10 μM Anti-proliferation effect ACS Chem Biol. 2013 Oct 18;8(10):2145-50.
Liver sinusoidal endothelial cells (LSECs) 70 nM 3 h DDR1-IN-1 did not significantly modify MMPs secretion in LSECs. Sci Rep. 2020 Oct 27;10(1):18398.
Kupffer cells (KCs) 70 nM 3 h DDR1-IN-1 reduced the expression of active MMP9 in KCs but did not significantly affect total MMPs secretion. Sci Rep. 2020 Oct 27;10(1):18398.
Hepatic stellate cells (HSCs) 70 nM 3 h DDR1-IN-1 decreased MMP2 and MMP9 secretion in HSCs and reduced the promotion of LSECs and C26 cell migration and proliferation by HSC-derived factors. Sci Rep. 2020 Oct 27;10(1):18398.
U2OS cells 105 nM 2 h Evaluate the inhibitory effect of DDR1-IN-1 on collagen-induced DDR1 autophosphorylation J Mol Biol. 2014 Jun 26;426(13):2457-70.
LN-229 4.99 µM 24 h Investigation of the effect of DDR1-IN-1 on the radiosensitivity of glioblastoma cells, showing that DDR1-IN-1 combined with cilengitide significantly enhanced radiosensitivity. Am J Cancer Res. 2023 Oct 15;13(10):4597-4612.
U-251MG 4.99 µM 24 h Investigation of the effect of DDR1-IN-1 on the radiosensitivity of glioblastoma cells, showing that DDR1-IN-1 combined with cilengitide significantly enhanced radiosensitivity. Am J Cancer Res. 2023 Oct 15;13(10):4597-4612.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice Colon carcinoma liver metastasis model Tail vein injection 1.5 mg/kg Three consecutive days, once daily DDR1 silencing reduced the number and size of metastatic foci in the liver and decreased collagen and MMPs activity in the tumor microenvironment. Sci Rep. 2020 Oct 27;10(1):18398.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.81mL

0.36mL

0.18mL

9.05mL

1.81mL

0.90mL

18.10mL

3.62mL

1.81mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories